ASXAppointment of CEO and Executive Director
other announcement
BIT
Pharmaceuticals, Biotechnology & Life Sciences
Biotron
- Short interest
- 0.03%
- +0.01 pp 30d
- as of 20 Nov 2025
- Reported shorts
- 421.6K
- Shares on issue
- 1.526B
Biotron (BIT) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Resignation of Managing Director and Appendix 3Z
other announcement
Google NewsBiotron Limited (ASX:BIT) Share Price Remains Unchanged as Stock Trades Within Daily Range - Kalkine
Biotron Limited (ASX:BIT) Share Price Remains Unchanged as Stock Trades Within Daily Range Kalkine
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
_07_03_2026_03_50_21_133108.jpg&w=3840&q=65)
KalkineBiotron Limited Lists 83.3 Million New Shares Following Performance Share Conversion
Biotron Limited has officially announced the listing of 83,333,333 new fully paid ordinary shares on the Australian Securities Exchange. This follows the conversion of performance shares into ordinary shares, marking a notable increase in the company's issued capital. This update is significant for investors tracking Biotron's capital management and growth strategies. Key Points Biotron Limited (ASX: BIT) Listing of 83,333,333 new ordinary shares Performance shares converted into ordinary sha...
Successful Issue of the Entitlement Offer Shortfall
capital_raise announcement
Change of Director's Interest Notice x 4
director_dealing announcement
Cancel - Notification regarding unquoted securities - BIT
other announcement